9:41 AM
Leo Group India
| ||
| Ahead of the Bell: Analyst downgrades Salix Pharma MSN Money (AP) - Cantor Fitzgerald raised its target price on Salix Pharmaceuticals after an 87 percent spike in shares this year, but it downgraded the company Monday on valuation. "One of our favorite names is finally fairly valued," analyst Irina Rivkind said. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment